Patents by Inventor Thomas LAUGHERY

Thomas LAUGHERY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination and Uses and Treatments Thereof
    Publication number: 20240091159
    Abstract: Methods are provided for treating or preventing human immunodeficiency virus-1 (HIV-1) or human immunodeficiency virus-2 (HIV-2) in a virologically suppressed patient in need thereof comprising switching the patient from an antiretroviral treatment regimen comprising at least three antiretroviral agents to a treatment regimen comprising only two antiretroviral agents. In one aspect the two treatment regimen consists of dolutegravir, rilpivirine and at least one pharmaceutically acceptable excipient, diluent or carrier. In another aspect of the invention, there is provided a multilayer tablet comprising dolutegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 7, 2023
    Publication date: March 21, 2024
    Applicants: ViiV Healthcare Company, Janssen Sciences Ireland Unlimited Company
    Inventors: Kenneth Churchill CAMPBELL, Urbain Alfons C. DELAET, James M. GOODRICH, Juliette Segolène GUAQUIÈRE, Thomas LAUGHERY, Dominique J. LIMET, John C. POTTAGE, Ludovic Sylvain Marc RENOU, Trevor R. SCOTT, Christian SEILER, Mary WOODWARD
  • REGIMENS FOR TREATING HIV INFECTIONS AND AIDS
    Publication number: 20220370466
    Abstract: Disclosed are methods for treating human immunodeficiency virus (HIV) or AIDS in a human subject using only two antiretroviral drugs, the subject being virologically suppressed and having previously followed a treatment regimen including at least three antiretroviral drugs.
    Type: Application
    Filed: May 25, 2022
    Publication date: November 24, 2022
    Inventors: Michael ABOUD, Pedro Cahn, Thomas Laughery, Dominique J. Limet, John C. Pottage, Kimberly Y. Smith
  • REGIMENS FOR TREATING HIV INFECTIONS AND AIDS
    Publication number: 20200147092
    Abstract: Disclosed are methods for treating human immunodeficiency virus (HIV) or AIDS in a human subject using only two antiretroviral drugs, the subject being virologically suppressed and having previously followed a treatment regimen including at least three antiretroviral drugs.
    Type: Application
    Filed: July 19, 2018
    Publication date: May 14, 2020
    Inventors: Michael ABOUD, Pedro CAHN, Thomas LAUGHERY, Dominique J. LIMET, John C. POTTAGE, Kimberly Y. SMITH
  • COMBINATION AND USES AND TREATMENTS THEREOF
    Publication number: 20200113838
    Abstract: Methods are provided for treating or preventing human immunodeficiency virus-1 (HIV-1) or human immunodeficiency virus-2 (HIV-2) in a virologically suppressed patient in need thereof comprising switching the patient from an antiretroviral treatment regimen comprising at least three antiretroviral agents to a treatment regimen comprising only two antiretroviral agents. In one aspect the two treatment regimen consists of dolutegravir, rilpivirine and at least one pharmaceutically acceptable excipient, diluent or carrier. In another aspect of the invention, there is provided a multilayer tablet comprising dolutegravir or a pharmaceutically acceptable salt thereof and rilpivirine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 27, 2018
    Publication date: April 16, 2020
    Inventors: Kenneth Churchill CAMPBELL, Urbain Alfons C. DELAET, James M. GOODRICH, Juliette Segolène GUAQUIÈRE, Thomas LAUGHERY, Dominique J. LIMET, John C. POTTAGE, Ludovic Sylvain Marc RENOU, Trevor R. SCOTT, Christian SEILER, Mary WOODWARD